StockNow
Log in
U.S. Markets

US FDA is reportedly to release draft guidance which aims to make the development of cell and therapy more streamlined, Axios reports

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Markets

Uber Technologies Inc. (UBER) Q2 2026 (USD): EPS 1.17 (exp. 0.81), Revenue 14.2bln (exp. 14.24bln), gross bookings USD 58bln (exp. 57.06bln)

UBER